KR100243981B1 - 결정상태의 에토포사이드 4'-포스페이트 디에탄올레이트 - Google Patents
결정상태의 에토포사이드 4'-포스페이트 디에탄올레이트 Download PDFInfo
- Publication number
- KR100243981B1 KR100243981B1 KR1019920018032A KR920018032A KR100243981B1 KR 100243981 B1 KR100243981 B1 KR 100243981B1 KR 1019920018032 A KR1019920018032 A KR 1019920018032A KR 920018032 A KR920018032 A KR 920018032A KR 100243981 B1 KR100243981 B1 KR 100243981B1
- Authority
- KR
- South Korea
- Prior art keywords
- etoposide
- phosphate
- diethanolate
- solution
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/773,056 US5648474A (en) | 1991-10-08 | 1991-10-08 | Crystalline etoposide 4'-phosphate diethanolate |
| US773056 | 1991-10-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR930007968A KR930007968A (ko) | 1993-05-20 |
| KR100243981B1 true KR100243981B1 (ko) | 2000-02-01 |
Family
ID=25097069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019920018032A Expired - Lifetime KR100243981B1 (ko) | 1991-10-08 | 1992-10-01 | 결정상태의 에토포사이드 4'-포스페이트 디에탄올레이트 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5648474A (https=) |
| EP (1) | EP0537555B1 (https=) |
| JP (1) | JP3205816B2 (https=) |
| KR (1) | KR100243981B1 (https=) |
| CN (1) | CN1030610C (https=) |
| AT (1) | ATE156832T1 (https=) |
| AU (1) | AU650572B2 (https=) |
| CA (1) | CA2079581C (https=) |
| CZ (1) | CZ283735B6 (https=) |
| DE (1) | DE69221573T2 (https=) |
| DK (1) | DK0537555T3 (https=) |
| EG (1) | EG20187A (https=) |
| ES (1) | ES2109970T3 (https=) |
| FI (1) | FI105034B (https=) |
| GR (1) | GR3025176T3 (https=) |
| HU (2) | HU213606B (https=) |
| IL (1) | IL103262A (https=) |
| MX (1) | MX9205777A (https=) |
| MY (1) | MY108969A (https=) |
| NO (1) | NO178342C (https=) |
| NZ (1) | NZ244521A (https=) |
| PH (1) | PH31666A (https=) |
| PL (1) | PL168332B1 (https=) |
| RU (1) | RU2042686C1 (https=) |
| SK (1) | SK298692A3 (https=) |
| TW (1) | TW239863B (https=) |
| ZA (1) | ZA926903B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5459248A (en) * | 1993-11-04 | 1995-10-17 | Bristol-Myers Squibb Company | Process of preparing etoposide phosphate and etoposide |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4670578A (en) * | 1983-08-29 | 1987-06-02 | Merck & Co., Inc. | Process for crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters |
| US4914222A (en) * | 1983-08-29 | 1990-04-03 | Merck & Co., Inc. | Crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process |
| US4713246A (en) * | 1984-03-19 | 1987-12-15 | Bristol-Myers Company | Etoposide oral dosage form |
| US4775751A (en) * | 1985-06-03 | 1988-10-04 | Eli Lilly & Company | Process for cephalexin hydrochloride alcoholates |
| US4927638A (en) * | 1986-10-08 | 1990-05-22 | Bristol-Myers Company | Etoposide solutions |
| US4904768A (en) * | 1987-08-04 | 1990-02-27 | Bristol-Myers Company | Epipodophyllotoxin glucoside 4'-phosphate derivatives |
| DE68912721T2 (de) * | 1988-11-16 | 1994-05-11 | Nippon Kayaku Kk | Kristallines Hydrochlorid von einer Etoposid-2-dimethylamino-Verbindung und Verfahren zur Herstellung davon. |
| US5081234A (en) * | 1990-04-30 | 1992-01-14 | Bristol-Myers Squibb Co. | 4'-demethylepipodophyllotoxin glycosides |
-
1991
- 1991-10-08 US US07/773,056 patent/US5648474A/en not_active Expired - Lifetime
-
1992
- 1992-03-07 TW TW081101734A patent/TW239863B/zh not_active IP Right Cessation
- 1992-09-10 ZA ZA926903A patent/ZA926903B/xx unknown
- 1992-09-11 MY MYPI92001632A patent/MY108969A/en unknown
- 1992-09-22 JP JP30024092A patent/JP3205816B2/ja not_active Expired - Lifetime
- 1992-09-23 IL IL103262A patent/IL103262A/xx not_active IP Right Cessation
- 1992-09-23 AU AU25301/92A patent/AU650572B2/en not_active Expired
- 1992-09-26 EG EG56692A patent/EG20187A/xx active
- 1992-09-28 NO NO923754A patent/NO178342C/no not_active IP Right Cessation
- 1992-09-28 NZ NZ244521A patent/NZ244521A/en not_active IP Right Cessation
- 1992-09-29 PL PL92296078A patent/PL168332B1/pl unknown
- 1992-09-29 FI FI924359A patent/FI105034B/fi not_active IP Right Cessation
- 1992-09-30 SK SK2986-92A patent/SK298692A3/sk not_active IP Right Cessation
- 1992-09-30 CZ CS922986A patent/CZ283735B6/cs not_active IP Right Cessation
- 1992-09-30 RU SU925052958A patent/RU2042686C1/ru active
- 1992-09-30 CA CA002079581A patent/CA2079581C/en not_active Expired - Lifetime
- 1992-09-30 EP EP92116749A patent/EP0537555B1/en not_active Expired - Lifetime
- 1992-09-30 AT AT92116749T patent/ATE156832T1/de active
- 1992-09-30 ES ES92116749T patent/ES2109970T3/es not_active Expired - Lifetime
- 1992-09-30 DK DK92116749.0T patent/DK0537555T3/da active
- 1992-09-30 CN CN92111350A patent/CN1030610C/zh not_active Expired - Lifetime
- 1992-09-30 DE DE69221573T patent/DE69221573T2/de not_active Expired - Lifetime
- 1992-09-30 PH PH45023A patent/PH31666A/en unknown
- 1992-09-30 HU HU9203119A patent/HU213606B/hu unknown
- 1992-10-01 KR KR1019920018032A patent/KR100243981B1/ko not_active Expired - Lifetime
- 1992-10-08 MX MX9205777A patent/MX9205777A/es unknown
-
1995
- 1995-06-22 HU HU95P/P00385P patent/HU211672A9/hu unknown
-
1997
- 1997-10-29 GR GR970402811T patent/GR3025176T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU615509B2 (en) | Temperature stable crystalline salts of 7-(alpha-(2- aminothiazol-4-yl)-alpha-(Z)-methoxyiminoacetamidol)-3- ((1-methyl-1-pyrrolidino)methyl)-3-cephem-4-carboxylate | |
| KR100403256B1 (ko) | 결정성n-아세틸뉴라민산유도체및그제조방법 | |
| RU2648990C1 (ru) | Кристаллы лобаплатина, способы получения и применения в фармацевтике | |
| IE862078L (en) | Cephalosporin salts | |
| KR100243981B1 (ko) | 결정상태의 에토포사이드 4'-포스페이트 디에탄올레이트 | |
| KR910008799B1 (ko) | 에피포도필로톡신 배당체의 4'-아실 유도체 | |
| KR960010947B1 (ko) | 2'-데옥시-2'메틸리덴시티딘 이수화물 이의 제조방법 및 조성물 | |
| EP0587121B1 (en) | Crystalline dihydrate of a cephalosporin dihydrochloride salt and injectable compositions thereof | |
| CN108997430A (zh) | 一种二丁酰环磷腺苷钙盐的晶体 | |
| CN104884128B (zh) | 力格赛狄盐及其晶型、它们的制备方法和用途 | |
| US4558053A (en) | Naphthalene-1,5-disulfonate salts of dimeric indole-dihydroindole alkaloids | |
| US5401842A (en) | Injectable compositions of a cephalosporin dihydrate salt | |
| EP0548834B1 (en) | Stable hexahydrate of etoposide 4'-phosphate disodium salt | |
| CN116496247A (zh) | 6-(1-丙烯酰基哌啶-4-基)-2-(4-苯氧基苯基)尼克酰胺的晶型 | |
| CN110790791A (zh) | 一种洛铂的无水合物晶体、制备方法及药物应用 | |
| EP4273116A1 (en) | Crystal form and amorphous form of honokiol, and preparation method therefor | |
| EP0400889B1 (en) | Crystalline deoxyspergualin and process for its preparation | |
| KR20230092805A (ko) | (2R, 3S)-2-(3-(4,5-디클로로-1H-벤조[d]이미다졸-1-일)프로필)피페리딘-3-올의 신규한 산부가염 및 결정형 | |
| KR20250013212A (ko) | N-(벤조일기)-페닐알라닌 파생 화합물의 결정체 및 그 약물 조성물, 제조 방법과 용도 | |
| KR940008595B1 (ko) | I-β-D-아라비노푸라노실시토신-5'-스테아릴포스페이트 모노나트륨염 모노하이드레이트 및 이 모노하이드레이트를 함유하는 약제 조성물 | |
| JPS6351385A (ja) | 新規なジアミノピリミド〔4,5−d〕ピリミジングリコシドおよびグリコチド | |
| HU196808B (en) | Process for producing crystalline monohydrate of /5r,6s/-2-amino-methyl-6-//1r/-1-hydroxy-ethyl/-2-peneme-3-carboxylic acid | |
| CN104045613A (zh) | (1s)-1-[4-氯-3-(4-乙氧基苄基)苯基]-1,6-二脱氧-d-葡萄糖和l-脯氨酸的共结晶i及其制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19921001 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19970905 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19921001 Comment text: Patent Application |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19991029 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 19991119 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 19991120 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20021107 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20031106 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20041109 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20051111 Start annual number: 7 End annual number: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20061110 Start annual number: 8 End annual number: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20071106 Start annual number: 9 End annual number: 9 |
|
| PR1001 | Payment of annual fee |
Payment date: 20081110 Start annual number: 10 End annual number: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 20091110 Start annual number: 11 End annual number: 11 |
|
| PR1001 | Payment of annual fee |
Payment date: 20101118 Start annual number: 12 End annual number: 12 |
|
| FPAY | Annual fee payment |
Payment date: 20111101 Year of fee payment: 13 |
|
| PR1001 | Payment of annual fee |
Payment date: 20111101 Start annual number: 13 End annual number: 13 |
|
| EXPY | Expiration of term | ||
| PC1801 | Expiration of term |
Termination date: 20130709 Termination category: Expiration of duration |